//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...









Loading...
ok the more I stare at the image of zero studies, the angrier I am. Wired, are you for real? Did you not check for a single study in a reputable journal, first? You're advertising snake oil to desperate people on what? a whim? I assumed a study had come out, at least, even if it was very poor.
Update: The email of the editor of the Alan Levinovitz Long Covid WIRED article whom letters and concerns can be directed to is available publicly here: jasonkehe.com 💌 [email protected]
🔥Levinovitz's article is a firestorm of conflation & misrepresentation He tries to reframe the community as toxic gatekeepers, whilst claiming there is a treatment but THEY are keeping it from you. Classic grift It's time to stop blaming patients' fear as being the problem
Breaking: The FDA appears to have approved the antiviral ensitrelvir (Xocova), which can be used as PEP after being exposed to someone with COVID-19 💊🦠 www.fda.gov/drugs/novel-...
"While the pathophysiology of #LongCovid remains incompletely understood, the knowledge gained has helped identify possible disease-modifying treatment targets, including several types of immunomodulatory, neurological, antiviral and other drugs"
16d
"Testing more disease-modifying treatments can have major scientific and social value at this time. Positive results from small, proof-of-concept trials can provide the rationale to conduct larger trials and attract much needed private investment in #LongCovid. Positive results..
"Because research budgets are limited, it is ethically imperative to optimize the scientific and social value of funded research. In our view, a pivot to more, well-designed, trials of disease-modifying treatments for #LongCovid follows from this imperative"